Stay updated on BEVZ92 Bioequivalence Study in mCRC Clinical Trial
Sign up to get notified when there's something new on the BEVZ92 Bioequivalence Study in mCRC Clinical Trial page.

Latest updates to the BEVZ92 Bioequivalence Study in mCRC Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has removed a detailed citation of a clinical trial regarding the bevacizumab biosimilar BEVZ92, which is significant as it pertains to core medical content.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the bioequivalence study of BEVZ92 and Avastin®, while retaining the registry identifier and a new revision number.SummaryDifference19%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to BEVZ92 Bioequivalence Study in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BEVZ92 Bioequivalence Study in mCRC Clinical Trial page.